TABLE 1.
The clinicopathological characteristics of HCC patients in the training set and validation set.
| Parameter | Total (%) | |
| TCGA | n = 370 | |
|
| ||
| Survival status | Alive | 244 (65.9) |
| Dead | 126 (34.1) | |
| Age | ≤65 years | 231 (62.4) |
| >65 years | 138 (37.3) | |
| Gender | Male | 249 (67.3) |
| Female | 121 (32.7) | |
| Histological grade | G1 | 55 (14.9) |
| G2 | 177 (47.8) | |
| G3 | 121 (32.7) | |
| G4 | 12 (3.2) | |
| Stage | I | 170 (45.9) |
| II | 86 (23.2) | |
| III | 85 (23.0) | |
| IV | 5 (1.4) | |
| T | T1 | 180 (48.6) |
| T2 | 94 (25.4) | |
| T3 | 80 (21.6) | |
| T4 | 13 (3.5) | |
| N | N0 | 251 (67.8) |
| N1 | 4 (1.1) | |
| NA | 115 (31.1) | |
| M | M0 | 265 (71.6) |
| M1 | 4 (1.1) | |
| NA | 101 (27.3) | |
|
| ||
| GSE14520 in GEO | n = 221 | |
|
| ||
| Survival status | Alive | 136 (61.5) |
| Dead | 85 (38.5) | |
| Gender | Male | 191 (86.4) |
| Female | 30 (13.6) | |
| Age | ≤65 years | 200 (90.5) |
| >65 years | 21 (9.5) | |
| Main tumor size | >5 cm | 80 (36.2) |
| ≤5 cm | 140 (63.3) | |
| MultiNodular | No | 176 (79.6) |
| Yes | 45 (20.4) | |
| TNM staging | I | 93 (42.1) |
| II | 77 (34.8) | |
| III | 49 (22.2) | |
| BCLC staging | 0 | 20 (9.0) |
| A | 148 (67.0) | |
| B | 22 (10.0) | |
| C | 22 (10.0) | |
| CLIP staging score | 0 | 97 (43.9) |
| 1 | 94 (42.5) | |
| 2 | 35 (15.8) | |
| 3 | 9 (4.1) | |
| 4 | 3 (1.4) | |
| 5 | 1 (0.5) | |